I see things very differently.
I view it as extremely positive move for shareholders and the science.
PYC science is now moving to the next stage of drug development and it will require people who have done that before.
Dr Watts hasn't done that before and it is too expensive in such situations to have senior people learning on the job.
PYC also can't keep paying big salaries to people who aren't able to deliver commercial outcomes.
I would expect to see some new executive appointments in the near term and hoping the CV's will reflect some big pharma experience and higher level commercial contacts.
- Forums
- ASX - By Stock
- PYC
- Ann: Director Appointment-PYC.AX
Ann: Director Appointment-PYC.AX, page-10
-
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.5¢ |
Change
0.010(7.41%) |
Mkt cap ! $676.5M |
Open | High | Low | Value | Volume |
13.5¢ | 15.0¢ | 13.5¢ | $1.160M | 8.003M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 344302 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 42942 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 30871 | 0.145 |
4 | 344380 | 0.140 |
9 | 634969 | 0.135 |
3 | 500900 | 0.130 |
4 | 509014 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 112942 | 2 |
0.150 | 1000000 | 2 |
0.155 | 357997 | 5 |
0.160 | 400576 | 2 |
0.165 | 428000 | 2 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |